 | • レポートコード：MRC2-11QY12451 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はIVDのグローバル市場について調査・分析したレポートです。種類別（免疫診断、化学診断、分子診断、POCT、その他）市場規模、用途別（糖尿病、感染症、腫瘍学/癌、心臓病、腎臓病、自己免疫疾患、薬物検査/薬理ゲノミクス、HIV/AIDS、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別IVDの競争状況、市場シェア ・世界のIVD市場：種類別市場規模 2015年-2020年（免疫診断、化学診断、分子診断、POCT、その他） ・世界のIVD市場：種類別市場規模予測 2021年-2026年（免疫診断、化学診断、分子診断、POCT、その他） ・世界のIVD市場：用途別市場規模 2015年-2020年（糖尿病、感染症、腫瘍学/癌、心臓病、腎臓病、自己免疫疾患、薬物検査/薬理ゲノミクス、HIV/AIDS、その他） ・世界のIVD市場：用途別市場規模予測 2021年-2026年（糖尿病、感染症、腫瘍学/癌、心臓病、腎臓病、自己免疫疾患、薬物検査/薬理ゲノミクス、HIV/AIDS、その他） ・北米のIVD市場分析：米国、カナダ ・ヨーロッパのIVD市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのIVD市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のIVD市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのIVD市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Diagnostics、Danaher Corporation、Abbott Laboratories、Siemens、Sysmex、Thermo Fisher Scientific、Becton, Dickinson and Company、Biomérieux Sa、Bio-Rad Laboratories、Johnson & Johnson、Agilent Technologies、Qiagen、Diasorin、Ortho Clinical Diagnostics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
Market Analysis and Insights: Global IVD Market
The global IVD market size is projected to reach US$ 7228.9 million by 2026, from US$ 7026.5 million in 2020, at a CAGR of 2.7%% during 2021-2026.
Global IVD Scope and Market Size
IVD market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global IVD market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche Diagnostics
Danaher Corporation
Abbott Laboratories
Siemens
Sysmex
Thermo Fisher Scientific
Becton, Dickinson and Company
Biomérieux Sa
Bio-Rad Laboratories
Johnson & Johnson
Agilent Technologies
Qiagen
Diasorin
Ortho Clinical Diagnostics
Market segment by Type, the product can be split into
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Other
Market segment by Application, split into
Diabetes
Infectious Diseases
Oncology/Cancer
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing/Pharmacogenomics
HIV/AIDS
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by IVD Revenue
1.4 Market by Type
1.4.1 Global IVD Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immuno Diagnostics
1.4.3 Chemistry Diagnostics
1.4.4 Molecular Diagnostics
1.4.5 POCT
1.4.6 Other
1.5 Market by Application
1.5.1 Global IVD Market Share by Application: 2020 VS 2026
1.5.2 Diabetes
1.5.3 Infectious Diseases
1.5.4 Oncology/Cancer
1.5.5 Cardiology
1.5.6 Nephrology
1.5.7 Autoimmune Diseases
1.5.8 Drug Testing/Pharmacogenomics
1.5.9 HIV/AIDS
1.5.10 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global IVD Market Perspective (2015-2026)
2.2 Global IVD Growth Trends by Regions
2.2.1 IVD Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 IVD Historic Market Share by Regions (2015-2020)
2.2.3 IVD Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 IVD Market Growth Strategy
2.3.6 Primary Interviews with Key IVD Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top IVD Players by Market Size
3.1.1 Global Top IVD Players by Revenue (2015-2020)
3.1.2 Global IVD Revenue Market Share by Players (2015-2020)
3.1.3 Global IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global IVD Market Concentration Ratio
3.2.1 Global IVD Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by IVD Revenue in 2019
3.3 IVD Key Players Head office and Area Served
3.4 Key Players IVD Product Solution and Service
3.5 Date of Enter into IVD Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global IVD Historic Market Size by Type (2015-2020)
4.2 Global IVD Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global IVD Market Size by Application (2015-2020)
5.2 Global IVD Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America IVD Market Size (2015-2020)
6.2 IVD Key Players in North America (2019-2020)
6.3 North America IVD Market Size by Type (2015-2020)
6.4 North America IVD Market Size by Application (2015-2020)
7 Europe
7.1 Europe IVD Market Size (2015-2020)
7.2 IVD Key Players in Europe (2019-2020)
7.3 Europe IVD Market Size by Type (2015-2020)
7.4 Europe IVD Market Size by Application (2015-2020)
8 China
8.1 China IVD Market Size (2015-2020)
8.2 IVD Key Players in China (2019-2020)
8.3 China IVD Market Size by Type (2015-2020)
8.4 China IVD Market Size by Application (2015-2020)
9 Japan
9.1 Japan IVD Market Size (2015-2020)
9.2 IVD Key Players in Japan (2019-2020)
9.3 Japan IVD Market Size by Type (2015-2020)
9.4 Japan IVD Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia IVD Market Size (2015-2020)
10.2 IVD Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia IVD Market Size by Type (2015-2020)
10.4 Southeast Asia IVD Market Size by Application (2015-2020)
11 India
11.1 India IVD Market Size (2015-2020)
11.2 IVD Key Players in India (2019-2020)
11.3 India IVD Market Size by Type (2015-2020)
11.4 India IVD Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America IVD Market Size (2015-2020)
12.2 IVD Key Players in Central & South America (2019-2020)
12.3 Central & South America IVD Market Size by Type (2015-2020)
12.4 Central & South America IVD Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics IVD Introduction
13.1.4 Roche Diagnostics Revenue in IVD Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 Danaher Corporation
13.2.1 Danaher Corporation Company Details
13.2.2 Danaher Corporation Business Overview
13.2.3 Danaher Corporation IVD Introduction
13.2.4 Danaher Corporation Revenue in IVD Business (2015-2020)
13.2.5 Danaher Corporation Recent Development
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Details
13.3.2 Abbott Laboratories Business Overview
13.3.3 Abbott Laboratories IVD Introduction
13.3.4 Abbott Laboratories Revenue in IVD Business (2015-2020)
13.3.5 Abbott Laboratories Recent Development
13.4 Siemens
13.4.1 Siemens Company Details
13.4.2 Siemens Business Overview
13.4.3 Siemens IVD Introduction
13.4.4 Siemens Revenue in IVD Business (2015-2020)
13.4.5 Siemens Recent Development
13.5 Sysmex
13.5.1 Sysmex Company Details
13.5.2 Sysmex Business Overview
13.5.3 Sysmex IVD Introduction
13.5.4 Sysmex Revenue in IVD Business (2015-2020)
13.5.5 Sysmex Recent Development
13.6 Thermo Fisher Scientific
13.6.1 Thermo Fisher Scientific Company Details
13.6.2 Thermo Fisher Scientific Business Overview
13.6.3 Thermo Fisher Scientific IVD Introduction
13.6.4 Thermo Fisher Scientific Revenue in IVD Business (2015-2020)
13.6.5 Thermo Fisher Scientific Recent Development
13.7 Becton, Dickinson and Company
13.7.1 Becton, Dickinson and Company Company Details
13.7.2 Becton, Dickinson and Company Business Overview
13.7.3 Becton, Dickinson and Company IVD Introduction
13.7.4 Becton, Dickinson and Company Revenue in IVD Business (2015-2020)
13.7.5 Becton, Dickinson and Company Recent Development
13.8 Biomérieux Sa
13.8.1 Biomérieux Sa Company Details
13.8.2 Biomérieux Sa Business Overview
13.8.3 Biomérieux Sa IVD Introduction
13.8.4 Biomérieux Sa Revenue in IVD Business (2015-2020)
13.8.5 Biomérieux Sa Recent Development
13.9 Bio-Rad Laboratories
13.9.1 Bio-Rad Laboratories Company Details
13.9.2 Bio-Rad Laboratories Business Overview
13.9.3 Bio-Rad Laboratories IVD Introduction
13.9.4 Bio-Rad Laboratories Revenue in IVD Business (2015-2020)
13.9.5 Bio-Rad Laboratories Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview
13.10.3 Johnson & Johnson IVD Introduction
13.10.4 Johnson & Johnson Revenue in IVD Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development
13.11 Agilent Technologies
10.11.1 Agilent Technologies Company Details
10.11.2 Agilent Technologies Business Overview
10.11.3 Agilent Technologies IVD Introduction
10.11.4 Agilent Technologies Revenue in IVD Business (2015-2020)
10.11.5 Agilent Technologies Recent Development
13.12 Qiagen
10.12.1 Qiagen Company Details
10.12.2 Qiagen Business Overview
10.12.3 Qiagen IVD Introduction
10.12.4 Qiagen Revenue in IVD Business (2015-2020)
10.12.5 Qiagen Recent Development
13.13 Diasorin
10.13.1 Diasorin Company Details
10.13.2 Diasorin Business Overview
10.13.3 Diasorin IVD Introduction
10.13.4 Diasorin Revenue in IVD Business (2015-2020)
10.13.5 Diasorin Recent Development
13.14 Ortho Clinical Diagnostics
10.14.1 Ortho Clinical Diagnostics Company Details
10.14.2 Ortho Clinical Diagnostics Business Overview
10.14.3 Ortho Clinical Diagnostics IVD Introduction
10.14.4 Ortho Clinical Diagnostics Revenue in IVD Business (2015-2020)
10.14.5 Ortho Clinical Diagnostics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. IVD Key Market Segments
Table 2. Key Players Covered: Ranking by IVD Revenue
Table 3. Ranking of Global Top IVD Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global IVD Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immuno Diagnostics
Table 6. Key Players of Chemistry Diagnostics
Table 7. Key Players of Molecular Diagnostics
Table 8. Key Players of POCT
Table 9. Key Players of Other
Table 10. Global IVD Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global IVD Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global IVD Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global IVD Market Share by Regions (2015-2020)
Table 14. Global IVD Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global IVD Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. IVD Market Growth Strategy
Table 20. Main Points Interviewed from Key IVD Players
Table 21. Global IVD Revenue by Players (2015-2020) (Million US$)
Table 22. Global IVD Market Share by Players (2015-2020)
Table 23. Global Top IVD Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD as of 2019)
Table 24. Global IVD by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players IVD Product Solution and Service
Table 27. Date of Enter into IVD Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global IVD Market Size by Type (2015-2020) (Million US$)
Table 30. Global IVD Market Size Share by Type (2015-2020)
Table 31. Global IVD Revenue Market Share by Type (2021-2026)
Table 32. Global IVD Market Size Share by Application (2015-2020)
Table 33. Global IVD Market Size by Application (2015-2020) (Million US$)
Table 34. Global IVD Market Size Share by Application (2021-2026)
Table 35. North America Key Players IVD Revenue (2019-2020) (Million US$)
Table 36. North America Key Players IVD Market Share (2019-2020)
Table 37. North America IVD Market Size by Type (2015-2020) (Million US$)
Table 38. North America IVD Market Share by Type (2015-2020)
Table 39. North America IVD Market Size by Application (2015-2020) (Million US$)
Table 40. North America IVD Market Share by Application (2015-2020)
Table 41. Europe Key Players IVD Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players IVD Market Share (2019-2020)
Table 43. Europe IVD Market Size by Type (2015-2020) (Million US$)
Table 44. Europe IVD Market Share by Type (2015-2020)
Table 45. Europe IVD Market Size by Application (2015-2020) (Million US$)
Table 46. Europe IVD Market Share by Application (2015-2020)
Table 47. China Key Players IVD Revenue (2019-2020) (Million US$)
Table 48. China Key Players IVD Market Share (2019-2020)
Table 49. China IVD Market Size by Type (2015-2020) (Million US$)
Table 50. China IVD Market Share by Type (2015-2020)
Table 51. China IVD Market Size by Application (2015-2020) (Million US$)
Table 52. China IVD Market Share by Application (2015-2020)
Table 53. Japan Key Players IVD Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players IVD Market Share (2019-2020)
Table 55. Japan IVD Market Size by Type (2015-2020) (Million US$)
Table 56. Japan IVD Market Share by Type (2015-2020)
Table 57. Japan IVD Market Size by Application (2015-2020) (Million US$)
Table 58. Japan IVD Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players IVD Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players IVD Market Share (2019-2020)
Table 61. Southeast Asia IVD Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia IVD Market Share by Type (2015-2020)
Table 63. Southeast Asia IVD Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia IVD Market Share by Application (2015-2020)
Table 65. India Key Players IVD Revenue (2019-2020) (Million US$)
Table 66. India Key Players IVD Market Share (2019-2020)
Table 67. India IVD Market Size by Type (2015-2020) (Million US$)
Table 68. India IVD Market Share by Type (2015-2020)
Table 69. India IVD Market Size by Application (2015-2020) (Million US$)
Table 70. India IVD Market Share by Application (2015-2020)
Table 71. Central & South America Key Players IVD Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players IVD Market Share (2019-2020)
Table 73. Central & South America IVD Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America IVD Market Share by Type (2015-2020)
Table 75. Central & South America IVD Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America IVD Market Share by Application (2015-2020)
Table 77. Roche Diagnostics Company Details
Table 78. Roche Diagnostics Business Overview
Table 79. Roche Diagnostics Product
Table 80. Roche Diagnostics Revenue in IVD Business (2015-2020) (Million US$)
Table 81. Roche Diagnostics Recent Development
Table 82. Danaher Corporation Company Details
Table 83. Danaher Corporation Business Overview
Table 84. Danaher Corporation Product
Table 85. Danaher Corporation Revenue in IVD Business (2015-2020) (Million US$)
Table 86. Danaher Corporation Recent Development
Table 87. Abbott Laboratories Company Details
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Product
Table 90. Abbott Laboratories Revenue in IVD Business (2015-2020) (Million US$)
Table 91. Abbott Laboratories Recent Development
Table 92. Siemens Company Details
Table 93. Siemens Business Overview
Table 94. Siemens Product
Table 95. Siemens Revenue in IVD Business (2015-2020) (Million US$)
Table 96. Siemens Recent Development
Table 97. Sysmex Company Details
Table 98. Sysmex Business Overview
Table 99. Sysmex Product
Table 100. Sysmex Revenue in IVD Business (2015-2020) (Million US$)
Table 101. Sysmex Recent Development
Table 102. Thermo Fisher Scientific Company Details
Table 103. Thermo Fisher Scientific Business Overview
Table 104. Thermo Fisher Scientific Product
Table 105. Thermo Fisher Scientific Revenue in IVD Business (2015-2020) (Million US$)
Table 106. Thermo Fisher Scientific Recent Development
Table 107. Becton, Dickinson and Company Company Details
Table 108. Becton, Dickinson and Company Business Overview
Table 109. Becton, Dickinson and Company Product
Table 110. Becton, Dickinson and Company Revenue in IVD Business (2015-2020) (Million US$)
Table 111. Becton, Dickinson and Company Recent Development
Table 112. Biomérieux Sa Business Overview
Table 113. Biomérieux Sa Product
Table 114. Biomérieux Sa Company Details
Table 115. Biomérieux Sa Revenue in IVD Business (2015-2020) (Million US$)
Table 116. Biomérieux Sa Recent Development
Table 117. Bio-Rad Laboratories Company Details
Table 118. Bio-Rad Laboratories Business Overview
Table 119. Bio-Rad Laboratories Product
Table 120. Bio-Rad Laboratories Revenue in IVD Business (2015-2020) (Million US$)
Table 121. Bio-Rad Laboratories Recent Development
Table 122. Johnson & Johnson Company Details
Table 123. Johnson & Johnson Business Overview
Table 124. Johnson & Johnson Product
Table 125. Johnson & Johnson Revenue in IVD Business (2015-2020) (Million US$)
Table 126. Johnson & Johnson Recent Development
Table 127. Agilent Technologies Company Details
Table 128. Agilent Technologies Business Overview
Table 129. Agilent Technologies Product
Table 130. Agilent Technologies Revenue in IVD Business (2015-2020) (Million US$)
Table 131. Agilent Technologies Recent Development
Table 132. Qiagen Company Details
Table 133. Qiagen Business Overview
Table 134. Qiagen Product
Table 135. Qiagen Revenue in IVD Business (2015-2020) (Million US$)
Table 136. Qiagen Recent Development
Table 137. Diasorin Company Details
Table 138. Diasorin Business Overview
Table 139. Diasorin Product
Table 140. Diasorin Revenue in IVD Business (2015-2020) (Million US$)
Table 141. Diasorin Recent Development
Table 142. Ortho Clinical Diagnostics Company Details
Table 143. Ortho Clinical Diagnostics Business Overview
Table 144. Ortho Clinical Diagnostics Product
Table 145. Ortho Clinical Diagnostics Revenue in IVD Business (2015-2020) (Million US$)
Table 146. Ortho Clinical Diagnostics Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Market Share by Type: 2020 VS 2026
Figure 2. Immuno Diagnostics Features
Figure 3. Chemistry Diagnostics Features
Figure 4. Molecular Diagnostics Features
Figure 5. POCT Features
Figure 6. Other Features
Figure 7. Global IVD Market Share by Application: 2020 VS 2026
Figure 8. Diabetes Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Oncology/Cancer Case Studies
Figure 11. Cardiology Case Studies
Figure 12. Nephrology Case Studies
Figure 13. Autoimmune Diseases Case Studies
Figure 14. Drug Testing/Pharmacogenomics Case Studies
Figure 15. HIV/AIDS Case Studies
Figure 16. Others Case Studies
Figure 17. IVD Report Years Considered
Figure 18. Global IVD Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global IVD Market Share by Regions: 2020 VS 2026
Figure 20. Global IVD Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global IVD Market Share by Players in 2019
Figure 23. Global Top IVD Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD as of 2019
Figure 24. The Top 10 and 5 Players Market Share by IVD Revenue in 2019
Figure 25. North America IVD Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe IVD Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China IVD Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan IVD Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia IVD Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India IVD Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America IVD Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Bottom-up and Top-down Approaches for This Report
Figure 33. Data Triangulation
Figure 34. Key Executives Interviewed
自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…- 感染症検査における分子診断の世界市場（～2026年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- POC分子診断の世界市場（～2026年） Market Analysis and Insights: Global POC Molecular Diagnostics Market The global POC Molecular Diagnostics market size is projected to reach US$ 654.1 million by 2026, from US$ 580.4 million in 2020, at a CAGR of 11.8%% during 2021-2026. Global POC Molecular Diagnostics Scope and Market Size POC Mol…
- 心臓ポイントオブケア（POC）診断の世界市場（～2026年） Market Analysis and Insights: Global Cardiology Point-of-Care (POC) Diagnostics Market The global Cardiology Point-of-Care (POC) Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cardiology Point-of-Care (POC…
- 自己免疫疾患診断の世界市場（～2026年） The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific. In terms of geography, the Americas led the …